Earlier this month, the World Health Organization WHO put out a warning against four paediatric medicines by Maiden Pharmaceuticals Limited.

The statement read that the products were “substandard medical products are products that fail to meet either their quality standards or specifications and are, therefore ‘out of specification.’”

The Abu Dhabi Department of Health has put out a notice confirming that all four of these medicines are not available in the emirate

The medicines were manufactured in Haryana, India.

Read the WHO Notice here.

Recommended

15 Ways To Celebrate Eid Al Fitr In Abu Dhabi!UAE Rulers Issued Condolences After Morocco Was Struck With A 6.8 Magnitude EarthquakeThe UAE Strongly Condemns The Burning Of Churches And Dozens Of Homes In Pakistan

 

View this post on Instagram

 

A post shared by دائرة الصحة – أبوظبي “DoH” (@dohsocial)

The Department also called on community members who may have obtained the product to not use them and to seek medical help in case of side effects following the usage of any

The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.

As per the WHO, “To date, these four products have been identified in The Gambia, but may have been distributed, through informal markets, to other countries or regions.”